Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human.
In this article are presented cumulative data dealing with the existence of more than one dopamine-receptor in mammals. In addition, evidence referring to the existence of two antagonistic dopamine-functional expressions in the human, is also presented. This fact along with the disclosure of new dopaminergic agonistic and antagonistic drugs will surely aid in the management of diseases in which these drugs have proven to be good therapeutic tools.
D000818:Animals; D001923:Brain Chemistry; D003106:Colon / Q000187:drug effects; D003913:Dextroamphetamine / Q000494:pharmacology; D004285:Dogs; D018492:Dopamine Antagonists; D004347:Drug Interactions; D005769:Gastrointestinal Motility / Q000187:drug effects*; D005951:Glucose Tolerance Test; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000097:blood; D011954:Receptors, Dopamine / Q000502:physiology*; D012701:Serotonin / Q000097:blood; D013469:Sulpiride / Q000494:pharmacology
D018492:Dopamine Antagonists; D007328:Insulin; D011954:Receptors, Dopamine; D012701:Serotonin; D013469:Sulpiride; D006220:Haloperidol; D003913:Dextroamphetamine